➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Dow
Colorcon
Medtronic
Johnson and Johnson

Last Updated: May 18, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Natural alpha interferon

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Natural alpha interferon?

Natural alpha interferon is an investigational drug.

There have been 29 clinical trials for Natural alpha interferon. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2015.

The most common disease conditions in clinical trials are Hepatitis, HIV Infections, and Pulmonary Disease, Chronic Obstructive. The leading clinical trial sponsors are National Cancer Institute (NCI), Amarillo Biosciences, Inc., and National Institute of Allergy and Infectious Diseases (NIAID).

There are two US patents protecting this investigational drug and fifty-seven international patents.

Recent Clinical Trials for Natural alpha interferon
TitleSponsorPhase
Polarized Dendritic Cell (aDC1) Vaccine, Interferon Alpha-2, Rintalolimid, and Celecoxib for the Treatment of HLA-A2+ Refractory MelanomaNational Cancer Institute (NCI)Phase 2
Polarized Dendritic Cell (aDC1) Vaccine, Interferon Alpha-2, Rintalolimid, and Celecoxib for the Treatment of HLA-A2+ Refractory MelanomaRoswell Park Cancer InstitutePhase 2
Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before SurgeryNational Cancer Institute (NCI)Phase 2

See all Natural alpha interferon clinical trials

Clinical Trial Summary for Natural alpha interferon

Top disease conditions for Natural alpha interferon
Top clinical trial sponsors for Natural alpha interferon

See all Natural alpha interferon clinical trials

US Patents for Natural alpha interferon

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Natural alpha interferon   Get Started Free Alpha interferon composition and method for its production from human peripheral blood leukocytes Interferon Sciences, Inc. (New Brunswick, NJ)   Get Started Free
Natural alpha interferon   Get Started Free Methods for making proteins containing free cysteine residues Bolder Biotechnology, Inc. (Louisville, CO)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Natural alpha interferon

Drugname Country Document Number Estimated Expiration Related US Patent
Natural alpha interferon Austria AT367398 2019-01-14   Get Started Free
Natural alpha interferon Austria AT375363 2017-07-14   Get Started Free
Natural alpha interferon Austria AT526401 2017-07-14   Get Started Free
Natural alpha interferon Australia AU2001274853 2017-07-14   Get Started Free
Natural alpha interferon Australia AU2002306305 2017-07-14   Get Started Free
Natural alpha interferon Australia AU2004231217 2017-07-14   Get Started Free
Natural alpha interferon Australia AU2413300 2017-07-14   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
McKesson
Baxter
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.